Today's Rundown Featured Story | | | Friday, May 17, 2019 Alongside pancreatic cancer, the aggressive brain cancer glioblastoma is one of the toughest cancers out there. Now, AbbVie is yet another biopharma learning that lesson firsthand. |
|
|
Top Stories Monday, May 20, 2019 British biotech is often a disregarded backwater when it comes to the international view of life sciences, but today a host of positive news has shone the spotlight back onto its potential. Monday, May 20, 2019 The pipeline of drugs and vaccines aimed at diseases prevalent in low- and middle-income countries has more than doubled since 2014, according to the Access to Medicine Foundation. However, the trend was driven by surging activity in noncommunicable diseases, leaving many conditions underserved by the current pipeline. Monday, May 20, 2019 Schrödinger has raised more money, bringing the total size of its recent haul up to $110 million. The computing-enabled R&D shop will use the money to advance its nascent pipeline of wholly owned drugs. Monday, May 20, 2019 The Medicines Company announced long-term data for its Alnylam-partnered inclisiran, showing that the drug consistently lowered “bad” LDL cholesterol by more than 50%. If approved, the twice-a-year injection will compete with anti-PCSK9 drugs from Amgen, Sanofi and Regeneron. Monday, May 20, 2019 Johnson & Johnson was ordered by a Philadelphia jury to pay $80 million to a woman whose vaginal mesh eroded, on the heels of a $120 million verdict issued against the company's Ethicon unit last month. | This week's sponsor is ExL Events. | |  | |
Resources Sponsored by: Catalent Download the executive summary to learn key considerations for a successful technology transfer for manufacturing drug products, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Patheon, part of Thermo Fisher Scientific Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs. Sponsored by: Patheon, part of Thermo Fisher Scientific Designed with speed & flexibility,Quick to Clinic™ for Oral Solid Dose helps deliver products to Phase I Clinic in as little as 14 weeks. Sponsored by: AlphaSense What is agile competitive intelligence, and how can help healthcare researchers stay ahead of the curve? Sponsored by: JPEO-CBRND – Medical Countermeasure Systems MCS is currently seeking broad-based industry/academia collaboration on research and prototype work in technical areas related to developing medical countermeasures for the Joint Warfighter. Sponsored by: Outer Edge Technology Learn how the cloud can support the performance and security requirements for validated, mission-critical applications historically designed and implemented exclusively via on-premises deployment. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. |
|
